TNXP Key Stats
- Tonix Pharmaceuticals to Present at the ROTH Conference GlobeNewswire 03/05 08:20 ET
- Tonix Pharmaceuticals (TNXP) Completes Pre-IND Meeting With FDA on TNX-201 Street Insider 03/03 09:39 ET
- 9:36 am Tonix Pharma completes pre-IND meeting with FDA on TNX-201 for episodic tension-type headache; will not require any additional nonclinical data to support a first-in-man study; clinical development to begin in 4Q 2014 Yahoo 03/03 09:36 ET
- Tonix Pharmaceuticals Completes Pre-IND Meeting With FDA on TNX-201 for Episodic Tension-Type Headache: Clinical Development to Begin in 4Q 2014 GlobeNewswire 03/03 09:35 ET
- Tonix Pharmaceuticals Spotlighted in Three Media Outlets in February GlobeNewswire 02/21 08:20 ET
- TONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statemen Yahoo 02/14 16:34 ET
- [video] Tonix CEO: Investors Seeing Value in Reformulation Strategy Yahoo 02/14 14:13 ET
- TONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Yahoo 02/10 09:02 ET
- TONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Yahoo 02/04 08:47 ET
- Tonix Pharmaceuticals to Present at the BIO CEO Conference GlobeNewswire 02/04 08:40 ET
TNXP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Tonix Pharmaceuticals is up 73.85% over the last year vs S&P 500 Total Return up 24.21%, Zogenix up 129.5%, and Pacira Pharmaceuticals up 185.2%.
Balance Sheet View Statement
Pro Ratings for TNXP
Pro Strategies Featuring TNXP
Did Tonix Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Headquarters Country: United States
- Headquarters State/Province: New York
- Incorporation Country: United States
- Incorporation State/Province: Nevada
Tonix Pharmaceuticals Holding Corp is a specialty pharmaceutical company focused on developing novel pharmaceutical products for challenging disorders of the CNS.